Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)

Gongwin Biopharm Holdings Revenue

Gongwin Biopharm Holdings had revenue of 7.63M TWD in the quarter ending March 31, 2025, with 40.14% growth. This brings the company's revenue in the last twelve months to 34.23M, up 40.50% year-over-year. In the year 2024, Gongwin Biopharm Holdings had annual revenue of 32.04M with 69.39% growth.

• Revenue (ttm): 34.23M
• Revenue Growth: +40.50%
• P/S Ratio: 401.27
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 13.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	32.04M	13.13M	69.39%
Dec 31, 2023	18.92M	17.77M	1,554.86%
Dec 31, 2022	1.14M	-	-
Dec 31, 2021	1.14M	310.00K	37.21%
Dec 31, 2020	833.00K	585.00K	235.89%